$ONCE – IPO Boutique

Secondaries Announced 9.21.17

Posted on September 21, 2017

IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]

Secondaries Announced 8.2.17

Posted on August 2, 2017August 2, 2017

IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]

Secondaries announced 8.15.2016

Posted on August 15, 2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Hospitality Properties Trust Symbol: HPT Price: Last trade $31.90 Description: Re-offer range $30.35-$31.30 Trade Date: 8/16 Shares: 11 million Underwriter(s) Citigroup,[…]

Secondaries announced 6.13.2016

Posted on June 13, 2016June 13, 2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: BioScrip Symbol: BIOS Price: Last trade $2.83 Trade Date: 6/17 Shares: 40 million Underwriter(s) Jefferies Rating=Subscription Needed Company: Comtech Telecommunications Corp.[…]

Secondaries announced 12.14.2015

Posted on December 14, 2015December 14, 2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Spark Therapeutics, Inc. Symbol: ONCE Price: Last trade $50.55 Trade Date: 12/16 Shares: 3 million Underwriter(s) J.P. Morgan, Cowen, Evercore, SunTrust[…]

Etsy set for debut, Aduro Biotech doubles

Posted on April 16, 2015April 16, 2015

The highly popular online marketplace for crafts, Etsy, will be going public today. The deal priced at the high end of the range–$16.00. What has been interesting to watch is the tussle between Wall Street and Main Street during the course of this roadshow.

January 2015 IPO Track Record Recap

Posted on February 3, 2015March 26, 2015

It was a lighter month in terms of quantity of IPOs that came to market in January. Just 13 deals came to market this month as compared to 17 deals that came to market in January 2014. But with what the new issues market lacked in number, it made up for it in quality with[…]

IPO Weekly Recap: Shake Shack and Spark Therapeutics Shine

Posted on January 30, 2015January 30, 2015

This past week ten IPOs debuted, six updated terms and zero new deals filed. Of the ten deals that came to market, two of them—Shake Shack (NYSE: SHAK) and Spark Therapeutics (Nasdaq: ONCE)—closed their opening day with more than a 100% premium above their respective offering prices. It was the first time two IPOs

IPO Pricings 1.29.2015

Posted on January 29, 2015January 29, 2015

Shake Shack (NYSE: SHAK) — Shake Shack prices deal above range. Shake Shack prices 5 million shares at $21 and will debut on Friday. Spark Therapeutics (Nasdaq: ONCE) — Spark Therapeutics upsizes IPO and prices above range. Spark prices 7 million shares at $23.00 and will debut on Friday. The revised range was 6.5 million[…]

IPOBoutique Brief: 1.28.2015 – Companies cashing in

Posted on January 28, 2015January 28, 2015

It appears that a pair of company’s who are IPO’ing this week are looking to take advantage of demand. Shake Shack (NYSE: SHAK) has increased the range from $14-$16 to $17-$19–representing a 20% increase if priced at the mid-point. Additionally, one of nine healthcare sector deals has not only increased its range, but its size[…]

IPOs Week Ahead: Week of 1.26.2015

Posted on January 26, 2015

Tuesday Zosano Pharma (Nasdaq: ZSAN) Wednesday Presbia PLC (Nasdaq: LENS) Thursday Ascendis Pharma A/S (Nasdaq: ASND) Entellus Medical (Nasdaq: ENTL) Flex Pharma (Nasdaq: FLKS) Friday Avinger (Nasdaq: AVGR) Infraredx (Nasdaq: REDX) InfraREIT (NYSE: HIFR) Shake Shack (NYSE: SHAK) Spark Therapeutics (Nasdaq: ONCE) Tracon Pharmaceuticals (Nasdaq: TCON) Subscribe now to get our full research report, IPO[…]

IPOBoutique Brief: 1.20.2015 — Flood of IPOs set terms

Posted on January 20, 2015

We expected 2015 to be a robust year for IPOs and were somewhat surprised that more deals did not come to market or set terms before MLK Day. However, that surprise was greeted with eight companies releasing official filings to the SEC setting terms for their respective IPOs. Avinger (Nasdaq: AVGR) – Trade Date: Week[…]